Company / Corporate
Veracyte.
Follow VeracyteSEC classifies Veracyte under Services-Medical Laboratories (SIC 8071).[1]
01Deal

Deals on Carrywatch
Every deal that names Veracyte, and its role in each.
Veracyte / C2i Genomics
Veracyte agrees to buy C2i Genomics
See deal detailsDeal Web
Veracyte and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Veracyte reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01SEC EDGAR company record for VERACYTE, INC.
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02Form 8-K Current Report, February 5, 2024
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Veracyte:
- P01VERACYTE, INC.: Veracyte / C2i Genomics
6 Feb 2024